Brief: Exicure Inc Received Notice Of Delisting From Nasdaq
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Steelcase, Otonomy
Brief: Exicure Announces Termination Of Abbvie And Ipsen Collaboration Agreements
Brief: Carlson Capital LP Reports 5.0% Passive Stake In Exicure Inc
Brief: Exicure Inc. Reports Third Quarter 2022 Financial Results, Provides Corporate Update
Exicure announces restructuring plan, shares fall
Brief: Exicure Inc Enters Into Definitive Agreement With CBI USA Inc For $5.4 Million Equity Financing
Brief: Exicure Reports Q2 2022 Financial Results And Corporate Progress
Exicure Inc reports results for the quarter ended in June - Earnings Summary
Exicure Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Exicure Inc Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Exicure Files Prospectus Related To Resale From Time To Time Of Up To 867,369 Shares Of Common Stock By Selling Stockholders
Brief: Exicure Announces Adjournment Of Annual Meeting Of Stockholders
Exicure Inc reports results for the quarter ended in March - Earnings Summary
Brief: Exicure Reports First Quarter 2022 Financial Results
Exicure Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tesla, Uber, Apple
Exicure plummets after flagging 'going concern' risk
Exicure Inc reports results for the quarter ended in December - Earnings Summary